|
Graduate Candidate
email: bookerl@vcu.edu
Curriculum
Vitae
Education
Research
interests
My
research interest focuses primarily on the endocannabinoid system, and the
regulation thereof. It has been
known for more than 20 years that cannabinoids are important research targets,
in that they have therapeutic potential for regulating diseases and disorders
including pain and inflammation. However, the use of direct acting
cannabinoids such as THC, which bind to cannabinoid receptors, has been
controversial, due to their undesirable psychoactive effects.
On the other hand, direct administration
of endocannabinoids is impractical, because these ligands are quickly degraded
by regulatory enzymes. Therefore, my goal is to evaluate the
indirect activation of the endocannabinoid system, via the use of selective
enzyme inhibitors, with the ultimate goal of reducing visceral pain and
inflammation.
Publications
| Pubmed
Long J.Z., Nomura D.K., Vann R.E., Walentiny D.M., Booker L., Jin
X., Burston J.J., Sim-Selley L.J., Lichtman A.H., Wiley J.L., Cravatt B.F.
Endocannabinoid crosstalk and its role in mammalian behavior revealed by dual
blockade of FAAH and MAGL (in press). Proc Natl Acad Sci
Booker
L, Naidu PS, Razdan RK, Mahadevan A, Lichtman AH. Evaluation of prevalent
phytocannabinoids in the acetic acid model of visceral nociception. Drug Alcohol
Depend. 2009 Nov 1;105(1-2):42-7.
Naidu
PS, Booker L , Cravatt BF, Lichtman AH. Synergy between enzyme
inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral
nociception. J Pharmacol Exp Ther. 2009 Apr;329(1):48-56.
Long,
J.Z., Li, W, Booker, L, Burston, J.J., Kinsey, S.G., Schlosburg, J.E.,
Pavon, F.J., Serrano, A.M., Selley, D.E., Parsons, L.H., Lichtman, A.H., &
Cravatt, B.F. Selective blockade of 2-arachidonoylglycerol hydrolysis produces
cannabinoid behavioral effects. Nat Chem Biol. 2009 Jan;5(1):37-44.
Copyright © 2007-2009 Aron H.
Lichtman, Ph.D. All Rights Reserved.
This page does not reflect an official position of Virginia Commonwealth
University.
|